BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 16799062)

  • 1. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between rat strains in models of retinopathy of prematurity.
    Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM
    Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.
    Leske DA; Wu J; Mookadam M; Chen Y; Fautsch MP; Holmes JM; Lanier WL
    Curr Eye Res; 2006 Feb; 31(2):163-9. PubMed ID: 16500767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
    Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM
    Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.
    Shaw LC; Li Calzi S; Li N; Moldovan L; Sengupta-Caballero N; Quigley JL; Ivan M; Jun B; Bazan NG; Boulton ME; Busik J; Neu J; Grant MB
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):858-869. PubMed ID: 29490339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
    van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
    Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
    Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
    Stitt AW; Graham D; Gardiner TA
    Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
    Akkoyun I; Yilmaz G; Oto S; Kahraman B; Haberal N; Akova YA
    Acta Ophthalmol Scand; 2007 Nov; 85(7):791-4. PubMed ID: 17488319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
    Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.